GILD DEF 14A DEF-14A Report May 12, 2011 | Alphaminr
GILEAD SCIENCES INC

GILD DEF 14A Report ended May 12, 2011

GILEAD SCIENCES INC
10-Ks and 10-Qs
10-Q
Quarter ended Sept. 30, 2024
10-Q
Quarter ended June 30, 2024
10-Q
Quarter ended March 31, 2024
10-K
Fiscal year ended Dec. 31, 2023
10-Q
Quarter ended Sept. 30, 2023
10-Q
Quarter ended June 30, 2023
10-Q
Quarter ended March 31, 2023
10-K
Fiscal year ended Dec. 31, 2022
10-Q
Quarter ended Sept. 30, 2022
10-Q
Quarter ended June 30, 2022
10-Q
Quarter ended March 31, 2022
10-K
Fiscal year ended Dec. 31, 2021
10-Q
Quarter ended Sept. 30, 2021
10-Q
Quarter ended June 30, 2021
10-Q
Quarter ended March 31, 2021
10-K
Fiscal year ended Dec. 31, 2020
10-Q
Quarter ended Sept. 30, 2020
10-Q
Quarter ended June 30, 2020
10-Q
Quarter ended March 31, 2020
10-K
Fiscal year ended Dec. 31, 2019
10-Q
Quarter ended Sept. 30, 2019
10-Q
Quarter ended June 30, 2019
10-Q
Quarter ended March 31, 2019
10-K
Fiscal year ended Dec. 31, 2018
10-Q
Quarter ended Sept. 30, 2018
10-Q
Quarter ended June 30, 2018
10-Q
Quarter ended March 31, 2018
10-K
Fiscal year ended Dec. 31, 2017
10-Q
Quarter ended Sept. 30, 2017
10-Q
Quarter ended June 30, 2017
10-Q
Quarter ended March 31, 2017
10-K
Fiscal year ended Dec. 31, 2016
10-Q
Quarter ended Sept. 30, 2016
10-Q
Quarter ended June 30, 2016
10-Q
Quarter ended March 31, 2016
10-K
Fiscal year ended Dec. 31, 2015
10-Q
Quarter ended Sept. 30, 2015
10-Q
Quarter ended June 30, 2015
10-Q
Quarter ended March 31, 2015
10-K
Fiscal year ended Dec. 31, 2014
10-Q
Quarter ended Sept. 30, 2014
10-Q
Quarter ended June 30, 2014
10-Q
Quarter ended March 31, 2014
10-K
Fiscal year ended Dec. 31, 2013
10-Q
Quarter ended Sept. 30, 2013
10-Q
Quarter ended June 30, 2013
10-Q
Quarter ended March 31, 2013
10-K
Fiscal year ended Dec. 31, 2012
10-Q
Quarter ended Sept. 30, 2012
10-Q
Quarter ended June 30, 2012
10-Q
Quarter ended March 31, 2012
10-K
Fiscal year ended Dec. 31, 2011
10-Q
Quarter ended Sept. 30, 2011
10-Q
Quarter ended June 30, 2011
10-Q
Quarter ended March 31, 2011
10-K
Fiscal year ended Dec. 31, 2010
10-Q
Quarter ended Sept. 30, 2010
10-Q
Quarter ended June 30, 2010
10-Q
Quarter ended March 31, 2010
10-K
Fiscal year ended Dec. 31, 2009
PROXIES
DEF 14A
Filed on March 28, 2024
DEF 14A
Filed on March 23, 2023
DEF 14A
Filed on March 24, 2022
DEF 14A
Filed on March 30, 2021
DEF 14A
Filed on March 24, 2020
DEF 14A
Filed on March 25, 2019
DEF 14A
Filed on March 26, 2018
DEF 14A
Filed on March 27, 2017
DEF 14A
Filed on March 28, 2016
DEF 14A
Filed on March 27, 2015
DEF 14A
Filed on March 24, 2014
DEF 14A
Filed on March 19, 2013
DEF 14A
Filed on March 20, 2012
DEF 14A
Filed on March 22, 2011
DEF 14A
Filed on March 22, 2010
TABLE OF CONTENTS
QUESTIONS AND ANSWERSINFORMATION CONCERNING SOLICITATION AND VOTINGGeneralSolicitationStockholder ProposalsVoting Rights and Outstanding SharesVoting in Person or by MailVoting Via the Internet or by TelephoneRevocability of ProxiesPROPOSAL 1 Election of DirectorsNomineesDirector Not Standing For Re-electionDirector EmeritusQualification of DirectorsBoard Committees and MeetingsExecutive OfficersPROPOSAL 2 Ratification of the Selection of Independent Registered Public Accounting FirmPrincipal Accountant Fees and ServicesPre-Approval Policy and ProceduresPROPOSAL 3 Approval of the Amended and Restated Gilead Sciences, Inc. Code Section 162(m) Bonus Plan and Certain Performance-based Provisions ThereunderPurposeEligible EmployeesAdministrationPerformance Goals/Performance PeriodsEstablishment of Performance ObjectivesCertification and Determination of BonusesMaximum Dollar Value of BonusesPayment of BonusesDuration and AmendmentFederal Income Tax ConsequencesNew Plan Benefits2010 Fiscal Year BonusesPROPOSAL 4 Approval of Amendments to Gileads Restated Certificate of Incorporation to Adopt Majority Voting StandardsPROPOSAL 5 Approval of Amendments to Gileads Amended and Restated Bylaws to Permit Holders of at Least 20% of the Voting Power of the Outstanding Capital Stock to Call a Special Meeting of StockholdersPROPOSAL 6 Advisory Vote on the Compensation of our Named Executive Officers as Presented in this Proxy StatementGeneralResolutionPROPOSAL 7 Advisory Vote as to the Frequency of Future Advisory Shareholder Votes on Executive CompensationSECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS